Article ID Journal Published Year Pages File Type
5701689 Journal of Thoracic Oncology 2017 21 Pages PDF
Abstract
This is the first study assessing the combination of EGFR and Janus kinase inhibition in patients with EGFR-mutant lung cancers. The combination was well tolerated but ineffective. Exosomal EGFR levels may reflect changes in tumor EGFR expression in response to therapy.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , ,